Epsilon Mol.Co
1 known investors
Epsilon Molecular Engineering develops and screens functional VHH (single-domain) antibodies using its cDNA display technology and proprietary PharmaLogical humanized antibody library, offering animal-free antibody discovery. It supports pharmaceutical and diagnostics companies with drug discovery, diagnostic reagent development, and next-generation cell manufacturing solutions.
Investors · 1
Frequently asked questions
- What does Epsilon Mol.Co do?
- Epsilon Molecular Engineering develops and screens functional VHH (single-domain) antibodies using its cDNA display technology and proprietary PharmaLogical humanized antibody library, offering animal-free antibody discovery. It supports pharmaceutical and diagnostics companies with drug discovery, diagnostic reagent development, and next-generation cell manufacturing solutions.
- Who are Epsilon Mol.Co's investors?
- Epsilon Mol.Co's investors include UntroD Capital.